✓ Medically reviewed by · Last reviewed: May 2026
Pharmacy Researcher · 8 years experience
Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.
HCG vs Semaglutide for Weight Loss: How the Two Mechanisms Compare
Quick Answer: Semaglutide and hCG are not actually comparable as weight-loss drugs because only one of them works. Semaglutide (Ozempic, Wegovy, Rybelsus) is a GLP-1 receptor agonist with multiple Phase 3 trials showing 10–17% sustained weight loss. HCG (human chorionic gonadotropin) has been marketed for weight loss since the 1950s under the Simeons protocol, but every controlled trial since the 1970s has shown that hCG-induced weight loss is identical to the very-low-calorie diet it accompanies — meaning hCG itself does nothing. If you’re choosing between them for weight loss, the choice isn’t between two options; it’s between an evidence-based therapy and a debunked one. This guide explains why.
What Each Drug Actually Does
Semaglutide: GLP-1 Receptor Agonism
Semaglutide is a long-acting analogue of glucagon-like peptide-1 (GLP-1), an incretin hormone the gut releases in response to food. It binds to GLP-1 receptors in the pancreas (boosting glucose-dependent insulin release), the stomach (slowing gastric emptying), and the hypothalamus (reducing appetite and increasing satiety).
The result is measurable: people eat less, feel full sooner, and experience reduced food noise — the persistent, intrusive thinking about food that’s a hallmark of obesity. Weight loss follows because energy intake drops.
Available as Rybelsus (oral, 3 mg / 7 mg / 14 mg daily) and as the injectable Ozempic and Wegovy formulations. For a complete buying guide see our Ozempic buying guide.
HCG: Human Chorionic Gonadotropin
HCG is the hormone the placenta produces in pregnancy. Clinically, it’s used in three legitimate contexts:
- Male hypogonadism / TRT fertility preservation — hCG signals testicular Leydig cells to produce testosterone and maintain spermatogenesis. See our HCG for men guide and the HCG dose protocol guide.
- Ovulation induction in female infertility — hCG mimics the LH surge to trigger ovulation.
- Post-cycle therapy after anabolic steroid use — hCG stimulates suppressed testes. See our HCG for PCT guide.
HCG has no mechanism by which it should affect adipose tissue or appetite. The 1950s claim by ATW Simeons — that hCG combined with a 500 kcal/day diet would mobilise “abnormal fat” while preserving muscle — was based on uncontrolled case series and has never been replicated under controlled conditions.
The Evidence Picture: A Stark Contrast
Semaglutide
Multiple Phase 3 randomised controlled trials, totalling more than 15,000 patients:
| Trial | Population | Duration | Mean weight change |
|---|---|---|---|
| STEP 1 (NEJM 2021) | Non-diabetic adults with obesity | 68 weeks | −14.9% (vs −2.4% placebo) |
| STEP 2 | Type 2 diabetes | 68 weeks | −9.6% (vs −3.4% placebo) |
| STEP 3 | Obesity + intensive behavioural therapy | 68 weeks | −16% (vs −5.7% placebo + IBT) |
| STEP 4 | Sustained vs withdrawn semaglutide | 68 weeks | −17.4% sustained vs +6.9% regain on withdrawal |
| STEP 5 (longest) | Obesity | 104 weeks | −15.2% (vs −2.6% placebo) |
The semaglutide STEP programme is one of the most consistently replicated weight-loss evidence bases in pharmacology. The drug also reduces cardiovascular events: SELECT (2023) showed a 20% reduction in major adverse cardiovascular events in adults with obesity and established cardiovascular disease.
HCG
The Cochrane-style evidence base for hCG diet weight loss:
Research spotlight: Lijesen et al’s 1995 systematic review of all available randomised trials of hCG for obesity found “no scientific evidence that hCG is effective in the treatment of obesity; it does not bring about weight-loss or fat-redistribution, nor does it reduce hunger or induce a feeling of well-being.” Every double-blind, placebo-controlled trial — Greenway 1977, Bosch 1990, Stein 1976, and others — found identical weight loss between hCG-injected and saline-injected groups, with both groups losing the weight predictable from the 500 kcal/day diet alone.
The FDA went on to mandate Boxed Warning labelling on all hCG products marketed for weight loss, and the FTC has prosecuted “homeopathic hCG” sellers for false advertising. Despite this, the Simeons diet persists in commercial weight-loss programmes, primarily because the 500 kcal/day calorie restriction does cause rapid short-term weight loss — credit then misattributed to the injection.
Side-Effect Profile Comparison
Semaglutide Side Effects
- Most common: Nausea (44% of users in STEP 1), diarrhoea, vomiting, constipation, abdominal pain — usually dose-related, peak in the first 12 weeks of dose escalation, mostly resolve.
- Important but uncommon: Acute pancreatitis (rare; stop immediately for severe abdominal pain radiating to back), gallbladder events (rapid weight loss increases stone risk), delayed gastric emptying (anesthesia caution).
- Theoretical / monitored: Thyroid C-cell tumours (seen in rodents; not confirmed in humans; contraindicated in personal/family history of medullary thyroid cancer or MEN2).
- Reversible: Loss of lean muscle mass — proportional to calorie deficit, addressed by resistance training during weight loss.
HCG Side Effects
When given for the legitimate clinical uses (TRT, fertility, PCT) at appropriate doses, hCG has a clean side-effect profile: occasional headache, breast tenderness in men (mild gynaecomastia from elevated aromatised oestrogen), and injection-site reactions. The risks specific to the Simeons weight-loss protocol come from the 500 kcal/day diet itself, not from hCG:
- Gallstones (rapid weight loss + low fat intake)
- Electrolyte disturbance and arrhythmia risk
- Loss of lean muscle mass (severe calorie restriction without adequate protein)
- Vitamin and mineral deficiencies
- Refeeding response and rapid weight regain post-protocol
The protocol’s main harm is teaching unsustainable behaviour patterns dressed up in pseudo-medical rigour.
“But I Lost Weight on HCG”
Many people genuinely do lose 10–15 kg over 6–8 weeks on the Simeons protocol. This is real weight loss. The reason it happens is the calorie restriction — 500 kcal/day is roughly an 80% deficit for most adults, which produces ~0.5–0.7 kg/week of fat loss plus 1–2 kg of initial glycogen and water loss.
The same weight loss happens on the same 500 kcal/day diet without hCG. The hCG injection adds the placebo effect, the financial commitment to the programme, and the sense of medical sanction — all of which support adherence, but none of which are pharmacological effects.
Long-term outcomes are the giveaway. Five-year follow-up on Simeons-protocol participants consistently shows near-complete weight regain, just like other very-low-calorie diet programmes. Semaglutide users who remain on therapy show sustained weight loss at 104 weeks; people who stop semaglutide regain ~2/3 of the weight within a year. The drug works as long as it’s taken.
So Why Is HCG Still Sold for Weight Loss?
Three reasons:
- Commercial inertia. The Simeons protocol has been a profitable cottage industry for 70 years. Clinics charge $1,000–$3,000 per 6-week round.
- Anecdotes are persuasive. People lose weight rapidly on the 500 kcal diet, attribute it to the injection, and recommend it.
- Selection bias. The people who finish the protocol are by definition the ones who could tolerate 500 kcal/day. They self-report success. The dropouts are invisible.
The proper clinical role of hCG is the three uses listed above — TRT fertility preservation, ovulation induction, and PCT — at clinically established doses. None of those involve daily 125–200 IU mini-doses for weight loss.
The Right Comparison Frame
If you’re considering hCG for weight loss, the honest framing is: “Should I take a 500 kcal/day very-low-calorie diet, with or without a useless injection?” The injection adds cost, needles, and effort without adding weight loss.
If you’re considering semaglutide for weight loss, the question is different: “Am I a candidate for GLP-1 therapy, what are the side effects I need to plan for, and what does the long-term protocol look like?” Those are legitimate clinical questions with real answers.
What About Other Comparators?
- Tirzepatide (Mounjaro/Zepbound) — dual GIP/GLP-1 agonist; produces ~21% weight loss in SURMOUNT-1, exceeding semaglutide. See Ozempic vs Mounjaro.
- Retatrutide — triple GIP/GLP-1/glucagon agonist in Phase 3; preliminary data suggests ~24% weight loss at 48 weeks. Already available in research-grade form as Retatrutide.
- Metformin — produces 2–4% weight loss; only modest by itself but synergistic with GLP-1 in some studies. See Metformin and weight loss.
- Orlistat (Xenical/Vyfat) — fat absorption inhibitor; modest 3–5% loss with high GI burden.
Frequently Asked Questions
Is “homeopathic hCG” the same as injectable hCG?
No. Homeopathic hCG drops sold for weight loss contain essentially no hCG. They are diluted past the point where any active molecule exists. The FDA and FTC have prosecuted multiple sellers. They have no biological effect at all.
Does hCG help with weight loss after pregnancy?
No. Postpartum hCG levels fall to zero within weeks regardless of breastfeeding. There’s no clinical rationale for hCG supplementation for postpartum weight loss.
What about hCG for men on TRT — does it cause weight loss?
No specific weight-loss effect. Men on TRT often experience body composition changes (more muscle, less fat) from the testosterone itself, not from hCG. HCG’s role in TRT is fertility and testicular size preservation, not adipose tissue effect.
What’s the right dose of semaglutide for weight loss?
The fully titrated Wegovy injectable dose is 2.4 mg weekly; the oral Rybelsus dose used for weight loss in trials is 25–50 mg daily (higher than the diabetes dose). Starting dose is much lower with stepped escalation over 16 weeks to manage GI side effects. See our Ozempic dosage chart.
Can I take semaglutide and hCG together?
If you’re a man on TRT with fertility preservation needs, you’d be taking hCG for testicular function and semaglutide separately for weight loss — they don’t interact pharmacologically. Combining them for weight loss specifically adds no benefit because hCG contributes nothing to weight loss.
What if I want to keep hCG in the picture?
If you want hCG for its legitimate purposes — TRT fertility preservation, ovulation induction, or PCT — the dosing protocols are well-established and the WHO-GMP products like HUCOG, Eutrig HP, and ZyHCG HP are reliable. For weight loss specifically, the literature says spend your money elsewhere.
Where MedsBase fits in
- Evidence-based weight loss: Rybelsus (oral semaglutide), Retatrutide research-grade peptide
- Adjacent options: Metformin (Diabetes Starter Pack), orlistat (Vyfat, Orligal-120)
- Legitimate hCG uses: TRT fertility, ovulation induction, PCT — WHO-GMP brands HUCOG, Eutrig HP, ZyHCG HP
- Worldwide shipping with discreet plain-envelope packaging and Reshipment Assurance
Medical Disclaimer: Weight-loss therapy with GLP-1 agonists requires baseline assessment, dose titration, and side-effect monitoring. Both semaglutide and HCG have legitimate clinical roles, but the evidence for HCG in weight loss specifically is negative. Always consult a qualified healthcare professional before starting or stopping any weight-loss medication.
Written by
Sophie ChenPharmaceutical Content Researcher · 8 years experience
Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.